Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • lmc
    Junior Member
    • Jun 2010
    • 6

    normalizing RNA-seq data to "unique transcript length" instead of "transcript length"

    I've clustered expression profiles from 20 experiments for a large group of highly related genes. I have the raw read counts and normalized this data using [total read counts uniquely matching to a gene]/[total counts in experiment]*[length of transcript]. However, because these genes have a large amount of non-unique sequence, I don't think that this method is correct. I'd like to try normalizing the expression data based on [length of unique k-mers within transcript] rather than [length of transcript]. Is there an existing tool that can calculate this?
    Thanks in advance any help!
  • mrawlins
    Member
    • Apr 2010
    • 63

    #2
    I'm not particularly impressed with the RPKM measure either, as it is still biased towards long transcripts (Oshlack and Wakefield, Biology Direct 2009). The method found in this paper (doi:10.1093/bioinformatics/btp692) seems to be a more intelligent way of addressing this issues, though I haven't yet tested it out. I'm not sure that [length of unique k-mers within transcript] will be any better than [length of transcript] at eliminating the bias you think is there.
    If you're set on doing it, though, I think you'll have to roll your own script to determine the length of unique k-mers, which may get to be fairly computationally intensive depending on how you go about doing that.

    Comment

    • steven
      Senior Member
      • Aug 2009
      • 269

      #3
      Originally posted by lmc View Post
      I've clustered expression profiles from 20 experiments for a large group of highly related genes. I have the raw read counts and normalized this data using [total read counts uniquely matching to a gene]/[total counts in experiment]*[length of transcript]. However, because these genes have a large amount of non-unique sequence, I don't think that this method is correct. I'd like to try normalizing the expression data based on [length of unique k-mers within transcript] rather than [length of transcript]. Is there an existing tool that can calculate this?
      Thanks in advance any help!
      Although it may not remove all the biases, subtracting non unique k-mers from the total transcript length before normalization makes sense. You can find some precomputed data in the "mapability" tracks at the UCSC for this purpose.
      Another thing: because of biases in the read coverage at the end of the transcripts, it is frequent to disregard the initial and terminal exons and/or the UTRs.
      good luck,
      s.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Working...